CS-2009
- Generic Name
- CS-2009
A Phase I Study of CS2009 in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- CStone Pharmaceuticals
- Target Recruit Count
- 230
- Registration Number
- NCT06741644
- Locations
- 🇨🇳
Linyi Cancer Hospital, Linyi, China
🇨🇳Shanghai East Hospital, Shanghai, China
🇦🇺Alfred Hospital (Alfred Health), Melbourne, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath